← Back to feedRead original →
VERIFIEDET Finance·neutral
Aurobindo Pharma launches generic Advair Diskus for asthma and COPD in US
AI Summary
- ·Lannett Company, a subsidiary of Aurobindo Pharma, has launched a generic version of Advair Diskus in the US.
- ·This marks Aurobindo Pharma's first complex inhalation product to be marketed in the US, a market valued at approximately $908 million.
- ·Cipla's US division has also received FDA approval for the same generic product.